Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CXApp Inc. Director's Dealing 2025

May 28, 2025

35018_dirs_2025-05-28_fd488910-627e-4b6c-b194-15509b808577.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CXApp Inc. (CXAI)
CIK: 0001820875
Period of Report: 2025-05-23

Reporting Person: Sheikh Khurram P (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-23 Class A Common Stock A 200000 Acquired 2716435 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-23 Stock Option (Right to Buy) $1.00 A 250000 Acquired 2035-05-23 Class A Common Stock (250000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Class A Common Stock 453530 Indirect

Footnotes

F1: On May 23, 2025, the Reporting Person was granted 200,000 Restricted Stock Units ("RSUs") as part of the annual compensation package for serving as a director of the Company. Each RSU represents a contingent right to receive one share of Class A common stock of CXApp Inc. The RSUs will vest in full on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Company through such date.

F2: Reflects securities held directly by JKSFS Crut, for which Mr. Sheikh is the trustee. Mr. Sheikh disclaims beneficial ownership of any such securities except to the extent of his pecuniary interest therein.

F3: On May 23, 2025, the Reporting Person was granted 250,000 stock options as part of the annual compensation package for serving as an employee of the Company. The shares subject to the options vest as follows: 1/3rd on the first anniversary of the grant date and 1/24th of the remaining options in equal monthly installments over the next 24 months.